DMEMEDS shared post via NYT: In Small Trials, 2 Drugs Go Far in Soothing Symptoms of Eczema and Psoriasis

An experimental drug for eczema relieved severity of symptoms in 85 percent of those who took it. A drug for psoriasis cut severity of symptoms in as many as 82 percent of those who took it. [Category: Johnson & Johnson|JNJ|NYSE, Clinical Trials, Skin, Drugs (Pharmaceuticals), Sanofi SA|SNY|NYSE, Eli Lilly and Company|LLY|NYSE, Novartis AG|NVS|NYSE, Amgen Inc|AMGN|NASDAQ, Psoriasis, Eczema, Regeneron Pharmaceuticals Inc|REGN|NASDAQ, Enbrel (Drug), AbbVie Inc|ABBV|NYSE] http://rss.nytimes.com/c/34625/f/640346/s/3c5953ac/sc/1/l/0L0Snytimes0N0C20A140C0A70C10A0Cbusiness0Cdrugs0Eshow0Epromise0Ein0Etreating0Eeczema0Eand0Epsoriasis0Ein0Etrials0Bhtml0Dpartner0Frss0Gemc0Frss/story01.htm

Read More